Clinical strategy for evaluation of anthracycline analogues.
D000818:Animals; D009202:Cardiomyopathies / Q000139:chemically induced; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D004317:Doxorubicin